Vlachogiannakos J, Kapatais A, Elefsiniotis IS, Koskinas J, Papageorgiou M-V, Manolakopoulos S, Gatselis N, Cholongitas E, Deutsch M, Karatapanis S, et al. Efficacy and safety of ombitasvir (OBV) and ritonavir boosted paritaprevir (PRV/r) with or without dasabuvir (DSV) regimens in genotype 1 or 4 HCV infected patients. A Greek multicenter real-life cohort study. In: HEPATOLOGY. Vol. 64. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2016. pp. 998A–998A. Copy at http://www.tinyurl.com/2d3tqmjv